DatasetName,PRKAR1B_S(184) PRKAR1B_S(7),PRKAR1B_S(3) PRKAR1B_S(73) PRKAR1B_S(75) PRKAR1B_S(77) PRKAR1B_S(83) PRKAR1B_S(9),PRKAR1B_S(13) PRKAR1B_S(14) PRKAR1B_T(85)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,,,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,,0.5771038215872301,
HS2024_6_B_T3,,0.4828158626150787,
JW2015_Intensity pre1,,,0.4063837805699813
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,,0.44670024121440544,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,0.504161711903683,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,0.5082417430933098,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,0.49592333200358457,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,0.4848226625740184,
HS2024_7_B_N1,,0.47318943196348245,
FSO2013_Ratio M/L normalized Rep1___1,,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,,0.5150737448675056,
WZ2023_Pu_010_30min,0.5783654934315041,0.49356744961332627,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,,
RB2022_8_RecoveryEndurance,,,
KBE2022_Log2_Ex_14_U,,0.49990773469974265,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,,,
PG2020_Intensity 8h_C,,0.49500662650722865,
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,0.5016494159992125,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.5143979251918996,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,,
GF2025_P6_Sph,,0.4523613137929803,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,,0.5860145535542799,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.5841506251703036,0.4958914253625139,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,0.49521404270502195,
KBE2022_Log2_Ex_34_U,,0.5172610794012061,
WZ2023_Pu_005_10min,0.5695335836789139,0.49289841569258974,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,,0.4764602490198571,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.5722593388016517,0.494399697193811,
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,,0.5341327100025884,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,0.502922879410404,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,,0.4971637506806517,
CR2017_Ratio Replicate 1.3,,0.47961575683079977,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,,
HS2024_7_PD_T2,,0.486769427046744,
FSO2013_Ratio H/L normalized Rep1___1,,,
AH2018_LFQ_1_C,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,,,
HS2024_3_B_N1,,0.46310466132494726,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.5826604842398797,0.49568552972939556,
CK2022_11 40-1,,0.4795006430816599,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,0.5171758148273522,
AH2018_SILAC_2_X,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,0.4921818383376579,
FSO2013_Ratio H/L normalized Rep2,,,
WZ2023_Pu_005_20min,0.5778629789638634,0.49397221093280047,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,0.5164789436075331,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,0.540524072734326,
HS2024_7_B_T3,,0.45851101257279697,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,0.4780081644656012,
HS2024_9_B_T2,,0.5684801708996124,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,0.46219707683107414,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,0.5076521190570561,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,0.4943569526130454,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,0.4966064480774326,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,,
CK2022_1 200-1,,,
PG2020_Intensity Mock_10h_D,,0.45852305135533705,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,0.4885644972052694,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,0.48149278201471907,
EP2017_Mitotic R#2 normalized log2 ratio,,0.4855488738974559,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,0.506233241083134,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,0.49475294815707155,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,,0.5252828123376293,
PG2020_Intensity 2h_C,,0.484175769412958,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,,0.5431447687329183,
KBE2022_Log2_Ex_8_T,,0.492215380432445,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,0.5103012799155254,
RN2012_L11,,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,0.5512864953614033,
AH2018_LFQ_M_2_C,,,
CK2022_3 40-1,,0.4777702770956185,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,0.5207744541225766,
YA2020_Reporter_intensity_Cancer_No.5,,,
HH2022_Reporter intensity 8,,,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,,
EJN2021_5_Rest_Basal,,0.49905231614992873,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,0.5427478677342396,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,,
YA2020_Reporter_intensity_Normal_No.1,,,
HS2024_3_B_T1,,0.5074396253154421,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,,0.5124543032316319,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,,0.4669401686223529,
HS2024_8_I_T3,,0.5318435596133577,
CF2017_EOC 3,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,0.4776682600321247,
HS2024_6_PD_T3,,0.46630153515365497,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.5749201734523173,0.4934999097800829,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,,0.47819872417586945,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,0.4958452774017162,
CK2022_8 16-1,,,
KS2014_Intensity N3,,0.4874236741055075,0.4025891946662905
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,,
FSO2013_Ratio H/M normalized Rep2,,,
RAM2015_Log2 A,,0.49930804271084334,
HS2024_8_PD_T1,,0.5094345118430735,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,0.48605378281892314,
KS2014_Intensity E15_2,,0.5065910558382031,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,0.4849467690351235,
HS2024_7_I_T1,,0.4893303471803477,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,0.4868604158257767,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,0.48209137602722424,
AH2018_SILAC_M_3_X,,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,0.4968510822978935,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,,0.5147604091567872,
HS2024_6_B_N1,,0.4317317702296642,
KBE2022_Log2_Ex_27_T,,0.5005480554170176,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,0.4755134893657594,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,0.3993816262312268
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,,,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,0.5094010207560996,
FSO2013_Ratio M/L normalized Rep2,,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,,
SR2019_HCC1954_Biol_repl_2,,0.4955690985576165,
CK2022_14 40-1,,0.48427698971882555,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,0.44457931802442374,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,,,
AR2021_ALG 10 μM,,0.5089712973933803,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,,
EJN2021_4_Rest_Ins,,0.49427393400820824,
RN2012_H05,,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,,0.5486364216858745,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,0.48622332790314476,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,,0.4978332477421668,
HH2022_Reporter intensity 3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,,
JW2021_After_3,,,
GF2025_P8_Sph,,0.47733208648964626,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,0.5136097797669728,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,,
CK2022_11 200-1,,,
CK2022_12 200-1,,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,,
WZ2023_Su_010_20min,0.5753539008951732,0.49096739090299496,
AH2018_TMTMS2_2_N,,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,0.5101769930044806,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,,0.38483104775061844
AH2018_TMTMS3_Pool,,,
KS2014_Intensity N4,,0.49264511937405725,0.3988153604852626
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,,,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,,
AST2020_anti-CD3+PDL2.2,,0.49621086404079645,
PG2020_Intensity Mock_10h_A,,0.47019797531388124,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,0.493802209700177,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,,
GF2025_P1_Adh,,0.5568329751670817,
GF2025_P1_Sph,,0.4746143713722573,
EJN2021_5_Ex_Basal,,0.5016236340891354,
HS2024_7_I_T3,,0.44646841646224716,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.5792352586108671,0.4930272073403767,
CF2017_EOC 1,,,
CK2022_3 200-1,,,
AH2018_LFQ_IT_3_C,,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,0.5065654859087657,
HS2024_6_PD_T2,,0.4925673739718606,
HS2024_5_B_T1,,0.5064182244427369,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,0.49293561979639605,
RB2022_6_PreStrength,,,
CK2022_2 40-1,,0.47816009258143516,
RB2022_1_PostSprint,,,
CK2022_4 200-1,,,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,,
AR2021_ALG 1 μM,,0.5539789296994535,
HS2024_4_B_T1,,0.46789914798449533,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,0.5073472291570059,
EJN2021_1_Rest_Basal,,0.4981321588129735,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,,0.5041196877005429,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,0.5105619936044019,
GF2025_P7_Adh,,0.5249670143274897,
CK2022_9 16-1,,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,,,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,0.4811476204531733,
CK2022_16 16-1,,,
FS2019_db/db3,,,
CK2022_15 40-1,,0.48505195878326246,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.5784716549683442,0.4930209916454742,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,0.5104917251427209,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,,
HS2024_5_PD_T3,,0.5060838228756317,
AH2018_TMTMS3_3_X,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,0.5133058562733122,
KBE2022_Log2_Ex_40_U,,0.49780099393539884,
AH2018_LFQ_M_1_N,,,
KBE2022_Log2_Ex_27_U,,0.5009204932101862,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,0.4936227985137102,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,,
RN2012_L13,,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,0.49357215037257546,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,0.4839635158682214,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,0.49011707696625423,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,0.4968756429144119,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,,0.48029793101029167,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,,
HH2022_Reporter intensity 6,,,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,,,
GF2025_P3_Adh,,0.5346655171663537,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,,,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,,
KBE2022_Log2_Ex_19_U,,0.5024161236675185,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,,
AST2020_Control,,0.49526897123642355,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,,,
YA2020_Reporter_intensity_Normal_No.3,,,
HS2024_8_B_T2,,0.48154623807434604,
AH2018_LFQ_1_X,,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,0.4835824551733576,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,0.48180344167882794,
HH2022_Reporter intensity 1,,,
HH2022_Reporter intensity 2,,,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,0.4674513956091608,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,,
SR2019_MCF7_Biol_repl_1,,0.4983236339229209,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,0.4946105130454684,
EP2017_Untreated R#2 log2 ratio,,0.5016842090516198,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,,0.5093232090358398,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,,
AR2021_KD 72h,,0.4611490568611436,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,,0.499030355345371,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,,
KBE2022_Log2_Ex_9_U,,0.49928511754114346,
AH2018_SILAC_M_3_N,,,
KBE2022_Log2_Ex_13_T,,0.4927638495047999,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,0.4783505796336834,
PG2020_Intensity Mock_10h_C,,0.44749303734588947,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,0.5001071116447058,
HS2024_7_B_N2,,0.45557699558290005,
PG2020_Intensity 10h_A,,0.5076377960799411,
RN2012_L12,,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,0.5040841543473878,
FSO2013_Ratio H/M normalized Rep1___1,,,
JW2015_Intensity cap2,,,0.4172039929300076
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,,0.48425495172640787,
RB2022_7_RecoveryEndurance,,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,0.4874690746120278,
TM2022_S2.12h.B,,,
RN2012_L15,,,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,0.4865985276554614,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,0.508908898559129,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,0.4876943132713539,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,,0.4609424643555529,
CK2022_7 200-1,,,
CK2022_5 200-1,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,0.5121013743119663,
AH2018_SILAC_3_C,,,
EJN2021_5_Rest_Ins,,0.49707620578528106,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,0.49524547201983965,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,,
CK2022_4 16-1,,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,0.49716524637694953,
EJN2021_2_Ex_Ins,,0.4705482116577319,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,0.45137244686455696,
FSO2013_Ratio H/L normalized Rep3,,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,0.4640877174571054,
KBE2022_Log2_Ex_9_T,,0.49670049450453124,
AH2018_SILAC_IT_2_N,,,
AH2018_SILAC_IT_1_X,,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,0.49650519018903,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,,0.5031542576197421,
WZ2023_Pe_025_20min,0.5831834625981387,0.49598145035723434,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,,
HS2024_4_I_N2,,0.5154276614881306,
AH2018_TMTMS2_3_N,,,
RN2012_H06,,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,0.526193656327695,
WZ2023_Su_005_30min,0.5776273785690539,0.4926910312092971,
SR2019_HCC1419_Biol_repl_4,,0.4848837545180637,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,0.4887430352366095,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,,0.4780210282720803,
WZ2023_Su_025_10min,0.5739864490333062,0.4890472272956618,
AH2018_LFQ_IT_4_X,,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.5738518271875634,0.49301307894943674,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,0.4680983677790895,
SFR2015_HL_log2_ratio_avg_a,,0.503309818996359,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,0.4851937383103974,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,,0.5177484975278249,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,,0.49916279623293575,0.395953814147518
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,0.48244663167056134,
LY2019_P7+,,,
EP2017_Untreated R#1 normalized log2 ratio,,0.477956066204293,
RN2012_L10,,,
PG2020_Intensity 4h_C,,0.44686645445576073,
EP2017_Mitotic R#3 normalized log2 ratio,,0.4895110010648221,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,0.4860198022588667,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,0.5069657048216398,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,,,
HS2024_4_B_T3,,0.5131152782912481,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,0.5256983171538889,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,0.49910199398203803,
KBE2022_Log2_Ex_6_U,,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,0.5072714726984843,
CR2017_Ratio Replicate 1.1,,0.49128310240694884,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,,,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.4890499368213635,
GF2025_P9_Sph,,0.46423032373563494,
CK2022_6 200-1,,,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,,0.5619760487337168,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,0.5146184662712264,
HS2024_4_PD_T1,,0.5410867225531718,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,0.5299386913471821,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,0.4643756066610969,
EP2017_Untreated R#3 normalized log2 ratio,,0.5068901298361143,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,,,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,0.5059939569084805,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.514163626771362,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,0.4802385184387052,
KBE2022_Log2_Ex_29_T,,0.49511228267035473,
HS2024_7_I_T2,,0.4599818077757578,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,0.5042580182561865,
HS2024_6_B_T2,,0.49421214570686955,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,0.4870179143957341,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,0.4957709988639223,
FR2021_Intensity.M,,0.4835824551733576,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,0.4885086304960152,
PG2020_Intensity CT_C,,0.4895490350738669,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,,,
EP2017_Untreated R#3 log2 ratio,,0.5064360534057434,
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,0.5107198179554602,
HS2024_8_PD_T2,,0.4752744664563871,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,0.49363977630975847,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,0.4988962026018115,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,,0.4869783991351298,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,,0.5526003389043436,
YA2020_Reporter_intensity_Normal_No.2,,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,0.49317240766327347,
HS2024_3_PD_T3,,0.44526160267885895,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,0.49941838507053665,
RAM2015_Log2 C,,0.5061617213491078,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,0.4987429089603493,
CK2022_2 16-1,,,
RAM2015_Log2 B,,0.5197554342300325,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,0.49549036564470744,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,0.4385012389540268,
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,0.3607402367972956
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,,0.47806634404432485,
PG2020_Intensity Mock_10h_B,,0.4949871005911391,
WZ2023_Su_025_30min,0.5728928270372783,0.4920897660657222,
AH2018_LFQ_4_N,,,
CR2017_Ratio Replicate 1.2,,0.4815253644378039,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,,0.5158280684914271,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,,
AH2018_SILAC_M_1_X,,,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,,0.5056098643197658,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,0.5130166626922351,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,0.5501353521708384,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,,0.49170752290552294,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,0.4975522038616503,
GF2025_P9_Adh,,0.5334315855691193,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,0.5129046559651154,
SR2019_BT549_Biol_repl_1,,0.5062872036528988,
AH2018_LFQ_M_4_N,,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,0.4184165954636165,
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,,0.47024263139322064,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,,0.5073060083100545,
GF2025_P3_Sph,,0.4522515923924139,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,0.4114168162272518
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,0.4436722294416265,
ZQ2022_N1,,,
LY2019_P6-,,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,0.38377742745201204
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,,,
AH2018_LFQ_3_N,,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,0.49775989124022374,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,,0.4949405288288356,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,0.5004713943963025,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,,0.4837527481068125,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,0.475132027530103,
SR2019_BT549_Biol_repl_2,,0.5102887900810994,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,,0.5083087759545294,
WZ2023_Su_025_20min,0.5702711754923755,0.49145237578000894,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,,0.4878590071612006,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,0.5222255082669588,
RN2012_H02,,,
PG2020_Intensity 10h_D,,0.46983718763189763,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,,0.45968633304136164,
EJN2021_4_Ex_Ins,,0.48430556362038363,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,0.5035340759401052,
EP2017_Pervanadate R#3 log2 ratio,,0.513811392429931,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,0.49849794926706575,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,,
CK2022_6 40-1,,0.48483064943501136,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,,,
LY2019_P3-,,,
FR2021_Intensity.A,,0.497986028779702,
EJN2021_3_Ex_Ins,,0.49093812212606136,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.5805741297548015,0.4947434803613507,
HS2024_8_PD_T3,,0.5194918260363973,
EJN2021_3_Ex_Basal,,0.49390214936529064,
AST2020_Control.1,,0.4961965009115541,
JW2015_Intensity cap1,,,0.4237865080635044
PG2020_Intensity CT_A,,0.49679132905981005,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.5782986767673484,0.49389605484926896,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,,0.5051366465311707,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,0.4948169771584949,
FR2021_Norm.Intensity.N,,0.48757204605875537,
HS2024_5_B_N1,,0.5209203836754585,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,,,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,,,
HS2024_8_I_N2,,0.4983418472077617,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,,
LY2019_P8+,,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,,0.3978840664411436
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,0.4746902782297013,
KBE2022_Log2_Ex_28_U,,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,
LY2019_P2-,,,
AH2018_LFQ_IT_1_X,,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,0.5795893308539777,0.4948364930339812,
AST2020_Control.2,,0.494594054531299,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,0.4502951112075478,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,0.5141419124559549,
CK2022_4 40-1,,0.47749105974146167,
SR2019_MCF10A_Biol_repl_4,,0.4789177686545873,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,0.49144981149934114,
HS2024_5_B_T2,,0.5133679946131013,
HS2024_6_I_T1,,0.4795190088728498,
HS2024_5_B_T3,,0.5579864239165134,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,,0.49926621865924564,
AH2018_TMTMS3_3_N,,,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,0.4875247065085495,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,,0.4901606416379783,
KBE2022_Log2_Ex_36_T,,0.4995082032621379,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.574387264656576,0.4936345091275325,
KS2014_Intensity C2,,0.485472301616402,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,,,
CK2022_9 200-1,,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,,,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,0.502415106160112,
RBK2021_1332T Late,,,
LY2019_P1-,,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,,0.46884175091725644,
HS2024_3_I_T3,,0.4863664249849222,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,0.5099346789151243,
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,,0.4946486114844217,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,,0.4775928562027278,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.5782001060360152,0.49401181461644295,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,0.4831574172384207,
HS2024_5_I_T3,,0.5204124735851812,
KS2014_Intensity N1,,0.48796917857161604,0.39615518735116956
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,,0.5028600350012842,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,0.4771612964807203,
PG2020_Intensity 2h_A,,0.4949705029730032,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,,
HS2024_5_B_N2,,0.48987328463407787,
HS2024_5_I_N1,,0.5025930686881651,
HS2024_6_I_N1,,0.4240963072813125,
AR2021_KD 48h,,0.5784312195424168,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,,0.5667625173478853,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,0.49531824971759747,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.5784617597501479,0.4932752233172772,
KBE2022_Log2_Ex_29_U,,0.49604242781973734,
HS2024_7_B_T1,,0.48466420461736953,
AH2018_LFQ_M_2_X,,,
AH2018_LFQ_IT_4_N,,,
CK2022_15 200-1,,,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,0.5165108370147098,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,0.5074820100697118,
CK2022_2 200-1,,,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.5776071267917815,0.49305018084069396,
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,0.49664913771117253,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.5181230380507947,
HS2024_8_B_T3,,0.4440758469971748,
YA2020_Reporter_intensity_Cancer_No.3,,,
KBE2022_Log2_Ex_44_U,,0.5097136319323367,
WZ2023_Pe_010_20min,0.5787396704049577,0.49354687857825047,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,,0.5046501616803406,
FSO2013_Ratio H/M normalized Rep3___1,,,
AH2018_SILAC_M_3_C,,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,0.5059125385571166,
AH2018_SILAC_M_2_C,,,
AH2018_SILAC_M_2_X,,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.5746301483118652,0.4913495896650351,
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,,,
CK2022_15 16-1,,,
CK2022_3 16-1,,,
LY2019_P4-,,,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,0.48769669865409115,
GF2025_P8_Adh,,0.5419962945377006,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,,0.47664818308685764,
CK2022_10 16-1,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,,0.48882840066075905,
EJN2021_2_Ex_Basal,,0.49812053190556815,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,0.4874161795085672,
AR2021_L41 10 μM,,0.45853868979199236,
CF2017_EOC 2,,0.4852019261606048,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,0.46319670629976967,
CK2022_6 16-1,,,
ZX2022_CB treated Replicate 1,,0.5690631379865573,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,,,
AR2021_L41 1 μM,,0.505580930856267,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,,0.5980956646506876,
KS2014_Intensity C4,,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,,0.4974871311543614,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,0.5189275431375263,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,,,
WZ2023_Pu_025_10min,0.5733360285285548,0.4943451043235239,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,,
SR2019_JIMT1_Biol_repl_4,,0.4993148374962375,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,0.4832353754011096,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.5768142818979974,0.49389925240336924,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,,
KS2014_Intensity C6,,,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,,0.4745178442143681,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,,0.5986055295598774,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,,0.48673562229104,
AH2018_SILAC_IT_2_C,,,
CK2022_5 40-1,,0.4826729506368872,
AH2018_LFQ_3_X,,,
UK2020_UA_3,,,
LY2019_P7-,,,
GF2025_P5_Adh,,0.5554977878899129,
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,,
SR2019_HCC1954_Biol_repl_3,,0.4997476946656623,
CR2017_Ratio Replicate 2.2,,0.49085036750117883,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,0.4918850581789027,
CK2022_11 16-1,,,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,,0.5094455183632095,
PG2020_Intensity CT_B,,0.47871563262256517,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,,
YA2020_Reporter_intensity_Cancer_No.4,,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,,0.45812647945412494,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,,0.5110248490461001,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,0.4943569526130454,
CK2022_14 16-1,,,
AST2020_anti-CD3+PDL2,,0.49544414520639285,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,0.49879580766920445,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,,0.48264301325093456,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,,0.48545492042303456,
AH2018_TMTMS2_1_X,,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,0.4979536890172273,
HS2024_6_I_N2,,0.4426599232364627,
HH2022_Reporter intensity 4,,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,0.4876990718378718,
HS2024_4_I_T3,,0.49155762660494634,
AH2018_SILAC_1_X,,,
PG2020_Intensity 10h_B,,0.4594108630359643,
AH2018_TMTMS3_1_X,,,
CF2017_FTE 14,,0.487591399303164,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,0.46775147066390804,
PG2020_Intensity 6h_A,,0.478726210996961,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,,0.5009040213235247,
EP2017_Untreated R#2 normalized log2 ratio,,0.5021708325313629,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,,
HS2024_5_I_N2,,0.5229065258894877,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,,0.5135400489002299,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
